The first and only FDA-approved, single-dose, sustained-release, intracameral steroid for the treatment of cataract postoperative inflammation
The first and only FDA-approved, single-dose, sustained-release, intracameral steroid for the treatment of cataract postoperative inflammation

The first and only FDA-approved, single-dose, sustained-release, intracameral steroid for the treatment of cataract postoperative inflammation1-3